Drug News

Syria's 'Poor Man's Cocaine': The drug that earned multibillion dollar for Bashar al-Assad, Iran, and Hezbollah, who will control the Captagon trade after Assad's fall?

Analiza Pathak December 12, 2024 11:15 AM IST

With Bashar al-Assad's regime in Syria now in decline, the future of his vast drug empire, particularly the Captagon trade, remains uncertain. For years, Syria has been the global hub for Captagon production, generating billions in revenue for Assad's family, the Syrian military, Iran, and Hezbollah.

Govt suspends licence of eye drop maker claiming no use of glasses

Vikas Mehta September 12, 2024 1:02 PM IST

The company said in a statement that the DCGI has approved the eye drop after a valid clinical trial was conducted on 234 patients which showed safety and efficacy of the eye drop. It said the patients of Presbyopia , who used the eye drop, were able to read lines on Snellen's Chart.

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts Cookies Policy.